Table 4 MVMR analysis of All-PA–leisure setting BMI as exposures
Exposure | Outcome | n | β (s.e.) | P value |
|---|---|---|---|---|
PA | Aneurysm (abdominal aortic) | 19 | −0.087 (0.055) | 0.11 |
BMI | Aneurysm (abdominal aortic) | 112 | 0.31 (0.18) | 0.092 |
PA | COVID-19 hospitalization | 19 | −0.067 (0.016) | 2.8 × 10−5 |
BMI | COVID-19 hospitalization | 113 | 0.37 (0.05) | 8.2 × 10−13 |
PA | asthma | 19 | −0.0069 (0.0026) | 6.7 × 10−3 |
BMI | asthma | 113 | −0.0035 (0.0086) | 0.69 |
PA | HDL-C | 19 | 0.0221 (0.0047) | 2.3 × 10−6 |
BMI | HDL-C | 113 | −0.042 (0.016) | 7.0 × 10−3 |
PA | Triglycerides | 19 | −0.038 (0.011) | 3.6 × 10−4 |
BMI | Triglycerides | 113 | 0.040 (0.035) | 0.26 |
PA | Type 2 diabetes | 16 | −0.058 (0.057) | 0.30 |
BMI | Type 2 diabetes | 101 | 0.42 (0.18) | 0.19 |
PA | Parental survival | 18 | 0.030 (0.010) | 2.9 × 10−3 |
BMI | Parental survival | 109 | −0.171 (0.034) | 4.4 × 10−7 |
PA | Phenotypic age acceleration | 19 | −0.091 (0.044) | 3.7 × 10−2 |
BMI | Phenotypic age acceleration | 113 | 0.92 (0.15) | 4.8 × 10−10 |
PA | Osteoarthritis | 19 | −0.0037 (0.0012) | 1.4 × 10−3 |
BMI | Osteoarthritis | 113 | 0.0253 (0.0039) | 1.3 × 10−10 |
PA | Gastroesophageal reflux disease | 19 | −0.063 (0.015) | 2.3 × 10−5 |
BMI | Gastroesophageal reflux disease | 113 | 0.141 (0.050) | 4.6 × 10−3 |
